Objective: To explore the effect of valproic acid, levetiracetam, oxcarbazepine on bone metabolism and quality of life in children.Methods: From January 2016 to June 2017,95 children with epileptic in Department of Pediatric,Cangzhou People's Hospital,were retrospectively analyzed,and were divided into VPA group, LEV group and OXC group according to antiepileptic drugs used, the three groups received treatment of valproic acid, levetiracetam, oxcarbazepine. Calcium, phosphorus, alkaline phosphatase, 25-(OH)D in serum and bone density of the three groups were compared before and after treatment, the occurrence of abnormal bone density was statistically and compared, usingverbal IQ(VIQ), performance IQ(PIQ),full scale IQ(FIQ) to evaluate the patients's neurocognitive status before and after treatment, the incidence of adverse reactions during the follow-up were statistically analyzed.Results: Serum calcium in VPA group decreased significantly after 1 year of treatment compared with before treatment(t=3.092,P=0.003), serum phosphorus in VPA group increased significantly after 1 year of treatment compared with before treatment(t=-4.939,P<0.001), alkaline phosphatase showed progressive increase after treatment(P<0.05), 25-(OH)Dand bone density decreased progressively after treatment(P<0.05).The incidence of abnormal bone densityin VPA group was significantly higher than that in the other two groups(Log rank χ2=8.568,7.430;P=0.003,0.006), the PIQ in VPA group was significantly decreased 1 year after treatment(t=18.348,P<0.001), the score of VIQ, PIQ, FIQ in LEV group were significantly increased 1 year after treatment(P<0.05). Conclusion: Levetiracetam has less effect on bone metabolism in children with epilepsy, it can also effectively improve neurocognitive ability quality of life. |
[1] BRODIE M J,BESAG F,ETTINGER A B,et al. Epilepsy,antiepileptic drugs,and aggression:an evidence-based review[J].Pharmacol Rev,2016,68(3):563-602.
[2] KOSSOFF E H,ZUPEC-KANIA B A,AUVIN S,et al. Optimal clinical management of children receiving dietary therapies for epilepsy:updated recommendations of the International Ketogenic Diet Study Group[J].Epilepsia Open,2018,3(2):175-192.
[3] 王栋梁,宋海栋,许可,等.新型抗癫痫药物临床应用研究[J].中国医学科学院学报,2019,41(4):566-571.
[4] RAHIMDEL A,DEHGHAN A,MOGHADAM M A,et al.Relationship between bone density and biochemical markers of bone among two groups taking carbamazepine and sodium valproate for epilepsy in comparison with healthy individuals in Yazd[J].Electron Physician,2016,8(11):3257-3265.
[5] ZHANG Y,ZHENG Y X,ZHU J M,et al. Effects of antiepileptic drugs on bone mineral density and bone metabolism in children:a meta-analysis[J].J Zhejiang Univ Sci B,2015,16(7):611-621.
[6] SCHEFFER I E,BERKOVIC S,CAPOVILLA G,et al.ILAE classification of the epilepsies:position paper of the ILAE Commission for Classification and Terminology[J].Epilepsia,2017,58(4):512-521.
[7] 金春华,王晓燕,张丽丽,等.健康儿童脂溶性维生素A、D、E现状分析[J].中华临床营养杂志,2016,24(6):349-353.
[8] 张元隆,梅文忠,游鸿海,等.认知功能评估在儿童中颅窝蛛网膜囊肿治疗策略选择中的临床意义[J].中华小儿外科杂志,2019,40(3):198-202.
[9] 刘晓军,张玉琴,宋毅军.儿童癫痫与睡眠的研究进展[J].国际生物医学工程杂志,2019,42(2):171-176.
[10] 李学超,王淼,王建忠,等.抗癫痫药物对癫痫患儿的骨代谢影响研究[J].实用药物与临床,2016,19(12):1516-1518.
[11] 杜悦新.骨碱性磷酸酶、血25-(OH)D联合其他实验室指标诊断小儿25-(OH)D缺乏性佝偻病的价值[J].中国妇幼保健,2017,32(15):3561-3563.
[12] 张双,庞保东,彭建霞,等.托吡酯与左乙拉西坦单药治疗儿童癫痫疗效及安全性分析[J].中国实用儿科杂志,2013,7(2):136-137.
[13] 梁英武,冯青,张延利,等.丙戊酸钠对癫痫患儿骨代谢的损害和钙D合剂的预防作用[J].中国当代儿科杂志,2017,19(9):962-964.
[14] 柯钟灵,林希,孙立军,等.丙戊酸对癫痫患儿骨代谢影响的Meta分析[J].中国循证儿科杂志,2013,8(5):356-362.
[15] ILI V,BOGIEVI D,MILJKOVI B,et al.Duration of valproic acid monotherapy correlates with subclinical thyroid dysfunction in children with epilepsy[J].Epileptic Disord,2016,18(2):181-186.
[16] KOO D L,JOO E Y,KIM D,et al.Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy[J].Epilepsy Res,2013,104(1-2):134-139.
[17] WEIJENBERG A,BROUWER O F,CALLENBACH P M.Levetiracetam monotherapy in children with epilepsy:a systematic review[J].CNS Drugs,2015,29(5):371-382.
[18] 马素红.25-(OH)D_3及钙剂联用对婴幼儿骨密度的影响及佝偻病疗效[J].黑龙江医药科学,2017,40(6):161-162.
[19] BAUER S,HOFBAUER L C,RAUNER M, et al.Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)-a prospective multicenter study[J].Epilepsy Res,2013,106(3):417-422.
[20] BREUER L,GREVERS E,BOON P,et al.Cognitive deterioration in adult epilepsy:clinical characteristics of "Accelerated Cognitive Ageing"[J].Acta Neurol Scand,2017,136(1):47-53.
[21] 李龙宽,谢娟,张玲敏,等.左乙拉西坦及奥卡西平对癫痫患儿丙戊酸钠及其代谢产物2-丙基-2-戊烯酸血药浓度的影响[J].中国医院药学杂志,2016,36(1):41-45.
[22] 王加朋,梁彩艳.丙戊酸钠、奥卡西平与左乙拉西坦分别治疗小儿癫痫的疗效及对认知功能的影响[J].药物评价研究,2017,40(5):687-690. |